Health Effects of Silver-Mercury Dental Fillings

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by University of Washington.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00066118
First received: August 4, 2003
Last updated: September 2, 2010
Last verified: September 2010

August 4, 2003
September 2, 2010
August 1996
July 2005   (final data collection date for primary outcome measure)
  • Memory
  • Rey Auditory Verbal Learning,
  • Finger Windows,
  • Visual Learning
  • Visual Motor Functions
  • Drawing, MatchingP
  • Pegboard sub-tests from the Wide Range Assessment of Visual Motor Abilities.
  • Attention/Concentration
  • Coding
  • Symbol Search
  • Digit Span
  • Standard Reaction Time
  • Stroop
  • Trails A and B.
  • Neurological: Nerve Conduction Velocity
Not Provided
Complete list of historical versions of study NCT00066118 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Health Effects of Silver-Mercury Dental Fillings
The Casa Pia Study of the Health Effects of Dental Amalgam in Children.

The purpose of this study is to determine whether there are detectable health effects of low-level mercury exposure (from normal exposure to mercury-containing dental fillings) in the known target organs/systems affected by elemental mercury exposure.

The Casa Pia Study of the Health Effects of Dental Amalgam in Children is a randomized, prospective clinical trial with the overall goal of determining if there are detectable health effects due to exposure from mercury-containing dental amalgam fillings. Children, thought to be the population most susceptible to any possible health effects, were randomly assigned to one of two treatment groups (total n=507). Subjects were originally enrolled at ages between 8-10 years of age. To participate, subjects must have: Dental caries in at least one posterior tooth; no prior exposure to dental amalgam; a blood lead of <15ug/L; a urinary mercury level of <10ug/L; an IQ as measured by the CTONI of >67; and no prior or existing serious medical or neurologic condition. One group received only dental filling materials other than those containing mercury (plastic and ceramic composites), while the other group received mercury amalgam fillings where appropriate (in large restorations in back teeth), but the alternative materials everywhere else. Both treatment regimens are standard-of-care throughout the world. Subjects receive ongoing dental care via the study clinics, and continue to receive dental fillings as needed based on group assignment. The target organs of mercury exposure are renal and neurological. Baseline and annual repeated measures are taken on all subjects for renal function, nerve conduction velocity and a large battery of neurobehavioral tests. Follow-up is planned for a period of 7 years

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Caries, Dental
Device: Dental amalgam restorations
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
507
February 2011
July 2005   (final data collection date for primary outcome measure)
  • Age 8-10 years of age
  • Dental caries in at least one posterior tooth.
  • No prior exposure to dental amalgam
  • Blood lead of <15ug/L
  • Urinary mercury level of <10ug/L
  • IQ as measured by the CTONI of >67
  • No prior or existing serious medical or neurologic condition
Both
8 Years to 12 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00066118
10085-A, U01DE011894, 95-0401-A 13, NIDCR-11894
Not Provided
DeRouen, Timothy Ph.D., University of Washington
University of Washington
National Institute of Dental and Craniofacial Research (NIDCR)
Principal Investigator: Timothy DeRouen University of Washington
Study Chair: Michael Martin University of Washington
University of Washington
September 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP